Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials

R. G. Langley, A. W. Armstrong, M. G. Lebwohl, A. Blauvelt, S. Hsu, S. Tyring, S. Rastogi, R. Pillai, R. Israel